JAK2(V617F) mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders

Leukemia. 2007 May;21(5):1097-9. doi: 10.1038/sj.leu.2404604. Epub 2007 Feb 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Base Sequence
  • Chronic Disease
  • DNA Primers
  • Female
  • Fluorescence
  • Humans
  • Janus Kinase 2 / genetics*
  • Male
  • Middle Aged
  • Mutation*
  • Myeloproliferative Disorders / genetics*

Substances

  • DNA Primers
  • JAK2 protein, human
  • Janus Kinase 2